Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6847
Source ID: NCT01322711
Associated Drug: Atorvastatin
Title: Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus|Hypercholesterolemia
Interventions: DRUG: Atorvastatin|DRUG: Placebo
Outcome Measures: Primary: Evaluation of effect of Atorvastatin Therapy in Hypercholesterolemic Patients (n=30) and Diabetic Patients (n=30), In Hypercholesterolemic patients (n=30) and in Diabetic patients (n=30) under chronic treatment with low dose aspirin (100 mg daily for at least 30 days), blood and urine samples were taken at each above reported time to evaluate the effect of atorvastatin or no treatment (Diet) on platelet recruitment, platelet and serum isoprostanes, platelet and serum thromboxane A2, platelet and serum NOX2 activation indexes, thrombin activation indexes, urinary excretion of thromboxane and isoprostanes., Baseline, 2 hours, 24 hours, 3 days, 7 days, 30 days |
Sponsor/Collaborators: Sponsor: University of Roma La Sapienza
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 60
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2011-03
Completion Date: 2015-12
Results First Posted:
Last Update Posted: 2015-05-28
Locations: Stefania Basili, Rome, 00161, Italy
URL: https://clinicaltrials.gov/show/NCT01322711